Health

XCMG Exports Special Epidemic Prevention Equipment to the Middle East, Assisting Global Partners in Fighting COVID-19

XUZHOU, China, April 10, 2020 /PRNewswire/ -- XCMG (SHE:000425) has delivered an order of multi-functional dust suppression vehicles to theMiddle East on March 30, marking a new milestone as the company's first bulk export of the product. The deal was completed on XCMG's Machmall.com platform and...

2020-04-10 18:17 5832

Huami Partnered with Nanshan Zhong's Team to Combat COVID-19 Coronavirus on a Joint Lab

SHENZHEN, China, April 10, 2020 /PRNewswire/ -- Huami (NYSE: HMI), announced a collaboration with China National Clinical Research Center of Respiratory Disease (NCRCRD) and Guangdong Nanshan Medical Innovation Institute, led by Dr. Nanshan Zhong, to establish a smart wearable joint laboratory. B...

2020-04-10 17:49 4223

AGC to Expand Its Spanish Synthetic Pharmaceutical Production Base for Capacity Increase and Establishment of New R&D Facility

TOKYO, April 10, 2020 /PRNewswire/ -- AGC Inc. (AGC), a world-leading manufacturer of glass, chemicals and high-tech materials, has announced its decision to expand facilities at its synthetic pharmaceutical (*1) CDMO (*2) business subsidiary, AGC Pharma Chemicals Europe S. L. U., headquartered i...

2020-04-10 14:00 2055

Samsung Biologics and Vir Biotechnology Enter into Agreement for Large Scale Manufacture of SARS-COV-2 Antibodies for Potential COVID-19 Treatment

SONGDO, South Korea and SAN FRANCISCO, April 9, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) and Vir Biotechnology, Inc. (Nasdaq: VIR) today announced a manufacturing agreement under which Samsung Biologics will perform large scale manufacturing services for Vir's SARS-CoV-2 monoclonal anti...

2020-04-10 11:39 2465

Estonia's Public and Private Sectors Come Together in E-Hackathon to Develop Innovative Solutions Admist the Crisis

TALLINN, Estonia, April 9, 2020 /PRNewswire/ -- On the day the state of emergency was declared inEstonia, a public-private e-hackathon was held as one of the first crisis responses to offer quick and feasible solutions to combat the impacts of COVID-19 outbreak. Estonia has a number of digital an...

2020-04-09 21:44 2291

JNCCN: Improving COVID-19 Safety for Cancer Patients and Healthcare Providers

PLYMOUTH MEETING, Pennsylvania, April 9, 2020 /PRNewswire/ -- The National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers--is continuing to share new resources for optimal cancer management amid new and changing challenges related to the Coronavirus Disease 2019 (COVI...

2020-04-09 20:35 1689

Seneca Biopharma Announces Results of Meeting with FDA Regarding the Design of Phase 3 Trial for NSI-566 in ALS

GERMANTOWN, Maryland, April 9, 2020 /PRNewswire/ -- Seneca Biopharma, Inc. (Nasdaq: SNCA), a clinical-stage biopharmaceutical company focused on developing novel treatments for diseases of high unmet medical need, today announced that the company held a Type C meeting with the Office of Tissues a...

2020-04-09 20:00 3093

Excelra Releases COVID-19 Drug Repurposing Database to Support Global Drug Development Efforts Against Novel Coronavirus

HYDERABAD, India, April 9, 2020 /PRNewswire/ -- Excelra, a leading global data and analytics company, today announced the release of the COVID-19 Drug Repurposing Database ( https://www.excelra.com/covid-19-drug-repurposing-database/ )....

2020-04-09 19:36 2566

Diageo donates ethyl alcohol to help combat COVID-19 in Southeast Asia

SINGAPORE, April 9, 2020 /PRNewswire/ -- Diageo, a global leader in beverage alcohol, has pledged to donate neutral spirit - a 96% strength ethyl alcohol used primarily in production of alcohol beverages, in support of efforts in Southeast Asia to tackle the challenge of COVID-19.

2020-04-09 19:11 2895

Merck and Pfizer Receive US FDA Breakthrough Therapy Designation and Submit Application for BAVENCIO(R) for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma

Not intended for US-, Canada- and UK-based media  -  Breakthrough Therapy Designation and Submission based on positive Phase III JAVELIN Bladder 100 study results -  Supplemental Biologics License Application being reviewed under FDA Real-Time Oncology Review (RTOR) pilot program -  JAVELIN B...

2020-04-09 18:00 4873

Infineon delivers millions of chips for medical ventilators

MUNICH, Germany, April 9, 2020 /PRNewswire/ -- Infineon Technologies AG (FSE: IFX / OTCQX: IFNNY) is playing a vital role to support the manufacturing of ventilator devices. Power semiconductors from Infineon are essential to reliably and efficiently control the motor of the ventilators, includin...

2020-04-09 16:05 5320

World-First Trial to Test Benefit of Intravenous Zinc in COVID-19 Fight

SYDNEY, April 9, 2020 /PRNewswire/ -- A world-first trial will see researchers from Austin Health and theUniversity of Melbourne use intravenous zinc to fight the symptoms of coronavirus (COVID-19). The trial will be led by Austin Health's Dr Joseph Ischia and Dr Oneel Patel from the Department ...

2020-04-09 15:57 1206

EHR Investments Increase as Governments and Healthcare Authorities Focus on Interoperability

Europe will see more partnerships for integrated care from the evolution of electronic health records, finds Frost & Sullivan LONDON, April 9, 2020 /PRNewswire/ -- The electronic medical record (EMR) market is likely to register impressive growth acrossEurope as it evolves into a morecomprehensi...

2020-04-09 15:50 1989

Bridge Biotherapeutics Discloses Interim Results from the First Cohort of Phase 2a Study of BBT-401, an Experimental Drug for Ulcerative Colitis

* The Interim data showed that 3 out of 9 evaluable patients on BBT-401 responded with more than 30% reduction in Total Mayo Score or 25% reduction in Partial Mayo Score * Safety and tolerability profiles remain consistent with results from Phase I trial in healthy volunteers SEONGNAM, South ...

2020-04-09 15:14 1226

Sustainable Travel Company Triip Launches Points Rewards System "Stay Home Heroes" to Support the World's Homebound Travelers

SINGAPORE, April 9, 2020 /PRNewswire/ -- Stay in, get paid. People under social distancing are now eligible for rewards in exchange for checking in safe at home, a new app feature launched by Triip to support a world staying in. In response to the March 25 call for action by the United Nations Wo...

2020-04-09 15:13 3315

Lam Research Commits $25 Million to COVID-19 Relief and Recovery Efforts

FREMONT, Calif., April 9, 2020 /PRNewswire/ -- Lam Research Corp. (Nasdaq: LRCX) today announced that it is committing $25 million for global COVID-19 relief and recovery efforts. The funds will be for short-term community assistance, including supplies to hospitals, longer-term recovery for com...

2020-04-09 12:17 4339

Qiming Venture Partners Raises $1.1 Billion Fund VII

SHANGHAI, BEIJING, HONG KONG and SHENZHEN, China, April 9, 2020 /PRNewswire/ -- Qiming Venture Partners today announced the closing of Qiming Venture Partners Fund VII, a new$1.1B fund focused on early stage Healthcare and TMT investments. Qiming is honored to have continued strong support from i...

2020-04-09 09:18 3805

RedDoorz partners with Governments across Southeast Asia to help frontline health workers combat the spread of COVID-19

SINGAPORE, April 9, 2020 /PRNewswire/ -- RedDoorz, Southeast Asia's largest and fastest-growing online hotel management and booking platform, today announced the launch of "Red Heroes", a new regional initiative that will provide free temporary accommodation for emergency services and frontline h...

2020-04-09 08:15 4233

Trip.com Group donates 3 million surgical masks to COVID-19 efforts

SHANGHAI, April 9, 2020 /PRNewswire/ -- Trip.com Group, a worldwide leading online travel services provider, has to date donated a total of 3 million surgical masks worldwide to COVID-19 efforts as part of its global initiative announced on18 March 2020. Further to the initial round of donations...

2020-04-09 08:00 4292

Samsung Biologics named Champion in 2020 CMO Leadership Awards

SONGDO, South Korea, April 8, 2020 /PRNewswire/ -- Samsung Biologics (207940.KS) announced that it has been awarded the 2020 CMO Leadership Awards for its excellence in the Capabilities, Compatibility, Quality, Reliability, and Service categories across Big Pharma and Overall (combined Big and Sm...

2020-04-08 20:00 1139
1 ... 714715716717718719720 ... 821